Published in

Lippincott, Williams & Wilkins, Journal of Acquired Immune Deficiency Syndromes, 5(69), p. 602-605, 2015

DOI: 10.1097/qai.0000000000000675

Links

Tools

Export citation

Search in Google Scholar

Brief Report

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

We surveyed trends in incidence (1995-2012) and risk factors for anal cancer in the Dutch HIV positive population. After an initial increase with a peak incidence in 2005-2006 of 114 (95% CI 74-169) in all HIV+ patients and 168 (95% CI 103-259) in HIV+ MSM, a decline is seen to 72 (95% CI 43-113) and 100 (95% CI 56-164) respectively in 2011-2012. Low nadir CD4, alcohol use and smoking were significantly associated with anal cancer in MSM. In conclusion, anal cancer remains a serious problem in predominantly HIV+ MSM. However, it seems that incidence rates are leveling off. Copyright